Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

30.84
BRL
-2.10
(-6.38%)
-3.34EPS
46.78BMarket Cap
Feb 10Next Earn

Arrowhead Pharmaceuticals, Inc. Documents

Q2 FY2026 · Presentation

Arrowhead June 2026 Summer Series Cardiomet RD Webinar Final · 57 pages

Read Arrowhead Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q2 FY2026 documents